Evidence map›Paper›PMID 33917784›Full record

ArticleHealthcare (Basel, Switzerland)2021

Mapping Evidence of Impacts of COVID-19 Outbreak on Sexual and Reproductive Health: A Scoping Review.

Obasanjo Afolabi Bolarinwa, Bright Opoku Ahinkorah, Abdul-Aziz Seidu, Edward Kwabena Ameyaw, Balsam Qubais Saeed, John Elvis Hagan, Ugochinyere Ijeoma Nwagbara

Abstract readScoping Review
PubMed Full text at PMC Publisher
In one paragraph

Article in Healthcare (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Obasanjo Afolabi BolarinwaDepartment of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban 4041, South Africa.ORCID 0000-0002-9208-6408
Bright Opoku AhinkorahSchool of Public Health, University of Technology Sydney, Sydney, NSW 2007, Australia.ORCID 0000-0001-7415-895X
Abdul-Aziz SeiduDepartment of Population and Health, University of Cape Coast, Cape Coast PMB TF0494, Ghana.ORCID 0000-0001-9734-9054
Edward Kwabena AmeyawSchool of Public Health, University of Technology Sydney, Sydney, NSW 2007, Australia.ORCID 0000-0002-6617-237X
Balsam Qubais SaeedDepartment of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.ORCID 0000-0002-3105-5501
John Elvis HaganDepartment of Health, Physical Education, and Recreation, University of Cape Coast, Cape Coast PMB TF0494, Ghana.ORCID 0000-0003-3530-6133
Ugochinyere Ijeoma NwagbaraDepartment of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban 4041, South Africa.ORCID 0000-0003-1771-0570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe emergence of the coronavirus disease 2019 (COVID-19) pandemic has rapidly transformed the pre-existing worldwide sexual and reproductive health environment. The provision and supply of contraceptives, and a wide variety of sexual health, new-born, and maternal health services have been seriously affected. Thus, this scoping review mapped the available evidence on the impacts of the COVID-19 outbreak on sexual and reproductive health.

methodsArksey and O'Malley's methodological framework guided this scoping review. A search was conducted from the following databases: Embase, PubMed, CINAHL, Scopus, WOS, and AJOL. The preferred reporting items for systematic reviews and meta-analyses (PRISMA) chart and PRISMA extension for scoping reviews (PRISMA-ScR) checklist were used to document the review process. The McMaster critical review checklist was used to determine the quality of the included studies. Thematic analyses were conducted using NVivo version 12.

resultsThree studies showed evidence on the impact of COVID-19 and family planning services, six studies reported on maternal and child services and eleven studies reported on sexual health (sexual behavior). Limited access to family planning use, reduction in multiple sexual partnership, decreased transactional sex, and maternal and child services disruption were some impacts reported in the included studies.

conclusionThis study has demonstrated the impacts of COVID-19 on family planning access, multiple sexual partnership, transactional sex, and disruption of maternal and child health services. Interventions that will consider the immediate availability of and access to all sexual and reproductive health services should be prioritized.

Indexed as

COVID-19family planningmaternal and child health servicessexual and reproductive healthsexual health

Identifiers

PMID33917784
PMCPMC8068100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.